Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

Dawson,

Thanks, but I’m not sure me still being here should offer solace to anyone. I have violated so many rules of investing when it comes to ADXS that it is embarrassing. The missed opportunity cost of having money invested in ADXS during one of the greatest bull runs in history is tremendous.

I cannot stress enough my disappointment that ADXS spent so much on the AXAL program, but has been unable to generate any revenue from it. With the failure (so far) to monetize HER2 and now AXAL, I have to agree (in principle) with those that say that ADXS has reset itself to a Phase I company for NEO and HOT.

At this point I think our best hope is that AMGN sees something so positive with early NEO results that they don’t want to wait until 2020 or 2021 to do something bigger than the current partnership.